Drug substance manufacturing
Our drug substance manufacturing solutions are designed to provide the flexibility you need to bring your biologic innovations to life.
How can our drug substance manufacturing solutions help you?
From conventional fed-batch to our continuous bioprocess manufacturing platform, EnzeneX™, we offer drug substance manufacturing solutions that push your project further.
EnzeneX™ continuous bioprocess manufacturing
- Our patented continuous bioprocess manufacturing platform represents the pinnacle of our ongoing commitment to innovation. EnzeneX™ harnesses the power of intensified perfusion using alternate tangential flow (ATF) and automated multi-column chromatography to achieve continuous production of biologics
Fed-batch manufacturing
- Our fed-batch drug substance manufacturing solutions can be adapted to the specific needs of your project or be used to support as you transfer to continuous manufacturing
Why partner with Enzene for drug substance manufacturing?
We are a global CDMO and biosimilar developer dedicated to impacting the global healthcare landscape by bringing trusted and affordable medicines to market, quickly.
Committed to innovation, we have revolutionized biologics production with our patented and validated continuous bioprocess manufacturing platform, EnzeneX™, that enables us to significantly reduce the cost of producing complex biologics and monoclonal antibodies (mAbs).
Our fully-integrated services and productive pipeline of biosimilars, along with our drug substance manufacturing solutions, are designed to cater to your project’s every need.
Related case studies
Latest resources
Join the manufacturing revolution
Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.